Physician profile
Michael J Kunstmann
NPI 1083655088
$4,179.35
in general payments reported to CMS, 2019-2025
19 companies · $588 in 2025
The $588 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,460 · 2020: $146 · 2021: $473 · 2022: $709 · 2023: $443 · 2024: $362 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,497.57 | 2019-2025 | Intrasight Mobile, IV Other |
| Medtronic, INC. | $709.71 | 2021-2025 | Endurant Iis, Venaseal, Closurerfs |
| Boston Scientific Corporation | $537.05 | 2020-2025 | Angiojet Ultra 5000a, Eluvia |
| Silk Road Medical, INC. | $323.64 | 2020-2022 | |
| Shockwave Medical, INC | $292.21 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| W. L. Gore & Associates, INC. | $278.13 | 2022-2025 | Gore Excluder Iliac Branch Endoprosthesis, C3 Delivery System, Gore Viabahn Vbx Balloon Expandable Endo |
| Endologix LLC | $151.28 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $140.94 | 2021 | |
| Cordis US Corp. | $46.19 | 2022-2023 | Rain Sheath Transradial |
| Lemaitre Vascular, INC. | $41.64 | 2019-2020 | |
| Medtronic Vascular, INC. | $27.16 | 2019 | |
| Atricure, INC. | $25.70 | 2023 | |
| Bridgebio Pharma, INC. | $23.87 | 2025 | Attruby |
| Amgen INC. | $18.22 | 2023 | Repatha |
| Cook Medical LLC | $15.98 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.06 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $13.23 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.46 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kunstmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.